Suzhou Fushilai Pharmaceutical Co., Ltd. (SHE:301258)
China
· Delayed Price · Currency is CNY 29.88
+0.81 (2.79%)
Apr 29, 2026, 4:00 PM EDT
SHE:301258 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Net Income | 37.59 | 64.29 | 16.41 | 112.18 | 177.31 | 120.2 | Upgrade
|
| Depreciation & Amortization | 48.01 | 48.01 | 48.5 | 56.64 | 51.87 | 46.11 | Upgrade
|
| Other Amortization | 1.27 | 1.27 | 1.82 | 0.74 | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.3 | 0.3 | 0.93 | 0.39 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | -47.49 | -47.49 | 18.77 | 2.64 | 5.92 | 4.25 | Upgrade
|
| Loss (Gain) From Sale of Investments | -31.8 | -31.8 | -29.44 | -24.97 | -2.82 | -4.24 | Upgrade
|
| Other Operating Activities | -0.41 | 2.73 | -2.81 | -2.68 | -24.7 | 3.11 | Upgrade
|
| Change in Accounts Receivable | 3.44 | 3.44 | -42.52 | 11.21 | -37.96 | -12.9 | Upgrade
|
| Change in Inventory | 24.81 | 24.81 | -0.61 | -34.24 | -57.81 | -11.22 | Upgrade
|
| Change in Accounts Payable | -3.98 | -3.98 | 39.89 | -27.35 | 27.34 | 49.22 | Upgrade
|
| Change in Other Net Operating Assets | - | - | - | - | 7.11 | 3.27 | Upgrade
|
| Operating Cash Flow | 36.75 | 66.6 | 47.07 | 94.77 | 151.19 | 199.73 | Upgrade
|
| Operating Cash Flow Growth | 42.70% | 41.50% | -50.33% | -37.32% | -24.30% | 19.71% | Upgrade
|
| Capital Expenditures | -166.14 | -146.5 | -105.31 | -41.62 | -50.11 | -80.75 | Upgrade
|
| Sale of Property, Plant & Equipment | -3.95 | 0.75 | 8.83 | 0.07 | 0.19 | 0.15 | Upgrade
|
| Investment in Securities | 317.33 | 275.57 | -42.61 | 69.26 | -1,138 | 100 | Upgrade
|
| Other Investing Activities | 40.93 | 32 | 39.97 | 20.86 | 13.79 | 10.71 | Upgrade
|
| Investing Cash Flow | 188.17 | 161.82 | -99.12 | 48.56 | -1,174 | 30.12 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | - | 18.56 | Upgrade
|
| Total Debt Issued | - | - | - | - | - | 18.56 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -18.56 | - | Upgrade
|
| Long-Term Debt Repaid | - | - | -0.71 | -0.71 | -0.48 | - | Upgrade
|
| Total Debt Repaid | - | - | -0.71 | -0.71 | -19.04 | - | Upgrade
|
| Net Debt Issued (Repaid) | - | - | -0.71 | -0.71 | -19.04 | 18.56 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 1,024 | - | Upgrade
|
| Repurchase of Common Stock | - | - | -20.14 | - | - | - | Upgrade
|
| Common Dividends Paid | -8.26 | -8.26 | -54.98 | -53.17 | -36.93 | -0.44 | Upgrade
|
| Dividends Paid | -8.26 | -8.26 | -54.98 | -53.17 | -36.93 | -0.44 | Upgrade
|
| Other Financing Activities | -78.47 | -79.13 | - | - | -25.25 | - | Upgrade
|
| Financing Cash Flow | -86.74 | -87.39 | -75.83 | -53.88 | 942.79 | 18.13 | Upgrade
|
| Foreign Exchange Rate Adjustments | -8.01 | -4.08 | 2.87 | 0.6 | 27.23 | -4.65 | Upgrade
|
| Net Cash Flow | 130.17 | 136.96 | -125.01 | 90.05 | -52.93 | 243.33 | Upgrade
|
| Free Cash Flow | -129.39 | -79.9 | -58.25 | 53.15 | 101.08 | 118.98 | Upgrade
|
| Free Cash Flow Growth | - | - | - | -47.42% | -15.05% | 17.62% | Upgrade
|
| Free Cash Flow Margin | -31.37% | -18.46% | -13.56% | 10.86% | 17.79% | 22.81% | Upgrade
|
| Free Cash Flow Per Share | -1.44 | -0.88 | -0.64 | 0.58 | 1.17 | 1.73 | Upgrade
|
| Cash Income Tax Paid | 13.3 | 20.52 | 1.25 | 17.95 | 7.95 | -9.3 | Upgrade
|
| Levered Free Cash Flow | -114.54 | -34.86 | -61.95 | 35.51 | 29.37 | 86.31 | Upgrade
|
| Unlevered Free Cash Flow | -114.54 | -34.86 | -61.9 | 35.58 | 29.56 | 86.59 | Upgrade
|
| Change in Working Capital | 29.28 | 29.28 | -7.11 | -50.18 | -56.39 | 30.31 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.